PRECISION BIOSCIENCES INC · Biotech

DTIL

Elevated riskNext report: In 6 days (est.)

View price ↗

The short version

A company still losing money with shrinking sales, with elevated risk. Insiders and institutions are both adding.

Going well

No debt reported

Watch out for

About 20 months of cash left at its current burn
Share count growing 63.6% a year (dilution)
Losing money, losses are large next to sales

Money moves

An insider bought $6K of shares with their own money in the last 30 days
Institutions added 9.4% to their holdings in the quarter ending June 2026 (62 bought, 27 sold)

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$6.41-3.5% that day

Latest insider buy: A director bought at $6.00 on Sep 28. The stock is now $6.41, +6.8% since.

Company value: $177M; Share price times all shares
Price vs sales: 3.9x; No profit over the last year, so this compares value with sales instead
Cash vs value: 49%; A big cushion: cash is a large part of what the company is worth

From DTIL's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

The business over time

Last 12 quarters, from SEC filings

Sales, Jun '26

Sep '23Tap a barJun '26

Last 12 months: $45.1M. Over 5 years, sales grew about 7.1% a year.

What the price assumes

Your guesses, our math

Move the sliders to your own view of DTIL. Starting points are the company's recent numbers (it isn't profitable yet, so the margin starts at a 10% guess).

Sales growth+7% a yearRecently: +7.1% a yearProfit margin10%Not reportedP/E at the end15xMany steady companies trade at 12x to 25xShare count change+10% a yearBelow zero means buybacks; above zero means new shares (dilution)

Sales in 5 years$63M

Profit in 5 years$6M

Price these guesses point to$2.13-67% vs $6.41 todayAbout -20% a year, before dividends

What today's price needs: with a 10% margin and a 15x P/E, sales would have to grow about 33% a year for 5 years just to match today's price.

Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.

Price

Price chart by TradingView.

Word of mouth

Updated daily

People looking up the company, yesterday: 1.8x normal; 9 views vs about 5 on a usual day

Forum talk counts mentions of DTIL in popular online stock forums, a slice of the internet rather than all of it. Company lookups show interest in the company itself, which can come from news that isn't about the stock. Attention isn't quality.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

1/6Weak

MissReturn on equity 15%+Earns a lot on the money owners have in the business.-61.5%
PassDebt under half of equityNot relying on borrowed money.No debt reported
MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.-133.4%
MissProfitable every yearSteady profits, not one good year.1 of 8 years
MissFree cash flow positiveBrings in more cash than it spends to run and grow.-$65.8M
MissShare count not growingNot diluting owners. Falling means buybacks.+337.8% in 3 years

Revenue: $34.3M; -50.1% vs prior year
5-year growth: +7.1%/yr; revenue, per year
Total debt: None; 0.00x equity
Current ratio: 13.32x; short-term assets / bills due

From annual reports filed with the SEC. Not in this company's SEC data, so not scored: gross margin 40%+. A checklist is a starting point for research, not a verdict.

Latest quarter

Quarter ended Jun 30, 2026

Reported Aug 6

Revenue: $0; -100.0% YoY
EPS: -$1.26; vs -$2.13
Free cash flow: -$13.4M
Share count: +134.1%; vs a year ago

Insider rating

Last 90 days

67Buying

3 insiders bought $30K

50 is neutral. Buying by more insiders, top executives and bigger stakes raises it. Selling lowers it; pre-planned sales count less.

Weekly insider trend

13 weeks agoBoughtSoldThis week

Filing buzz

Last 7 days vs normal

0/ 100

This week: 0
Normal week: 1.0
vs normal: 0.0x

SEC filings of any kind. 50 means a normal week.

Institutional ownership

Accumulating+9.4%

Institutions added 9.4% to their holdings. 62 bought, 27 sold. 5 quarters of net buying in a row.

Shares held by institutions17.7M

Sep '24Jun '26

Safety check

From SEC filings

Share count growthYearly rate, last 3 years

-37.8%

Cash runwayAt last year's cash burn

16 months

Debt to equityLatest balance sheet: debt compared with what owners have

No debt reported

Shares outstandingLatest reported

28M

Why elevated risk

Losing money, losses are large next to sales
About 16 months of cash left at its current burn
Revenue down 50.1% from the year before

Earnings reports

Last 12

Next reportIn 6 days (est.)Estimated from the same quarter last year

Results filedAug 6
Results filedMay 5
Results filedMar 12
Results filedJan 13
Results filedNov 3, 2025

Flags and big holders

Offerings 6 months, flags 12 months, holders 90 days

5%+ holder update (passive)Aug 24 · View filing ↗Big holder 5%+ holder update (passive)Jul 29 · View filing ↗Big holder

Insider trades

Open-market buys and sells, last 90 days

Bought$30K3 insiders

Sold$00 insiders

Insider	Trade	Shares	Avg price	Value	Owns after	Date
Stanley FrankelDirector	Buy	1K	$6.00	$6K	41K	Sep 28Filing ↗
+2.5% of their holdings Filed 2 days after
Melinda BrownDirector	Buy	1K	$6.27	$7K	45K	Sep 25Filing ↗
+2.6% of their holdings Filed 4 days after
Geno J GermanoDirector	Buy	3K	$6.28	$16K	47K	Sep 25Filing ↗
+5.8% of their holdings Filed 4 days after

"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.

Latest filings

Straight from SEC EDGAR

BoughtStanley FrankelDirector

1,000 shares at $6.00 · $6K

+2% of holdings
Now owns 41,478 shares
Filed 2 days after trade

Sep 28Form 4 ↗

BoughtGeno J GermanoDirector

2,609 shares at $6.28 · $16K

+6% of holdings
Now owns 47,492 shares
Filed 4 days after trade

Sep 25Form 4 ↗

BoughtMelinda BrownDirector

1,135 shares at $6.27 · $7K

+3% of holdings
Now owns 45,481 shares
Filed 4 days after trade

Sep 25Form 4 ↗

Investor disclosureAug 24 · Form 8-K ↗5%+ holder update (passive)Aug 24 · Form SCHEDULE 13G/A ↗Employee stock plan registrationAug 7 · Form S-8 ↗Earnings resultsAug 6 · Form 8-K ↗Quarterly reportAug 6 · Form 10-Q ↗New insiderAug 3 · Form 3 ↗New insiderAug 3 · Form 3 ↗New insiderAug 3 · Form 3 ↗5%+ holder update (passive)Jul 29 · Form SCHEDULE 13G/A ↗Leadership changeJul 27 · Form 8-K ↗New 5%+ holder (passive)Jul 20 · Form SCHEDULE 13G ↗Investor disclosureJul 1 · Form 8-K ↗

Source: SEC EDGAR filings. For informational purposes. Not investment advice.

Report a problem with this page